Cargando…

Proton pump inhibitor use increases hepatic encephalopathy risk: A systematic review and meta-analysis

BACKGROUND: Several studies have been conducted to explore the association between the use of proton pump inhibitors (PPIs) and hepatic encephalopathy (HE) risk in patients with liver cirrhosis. However, their results are controversial. AIM: To perform a systematic review and meta-analysis to evalua...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Yun-Jie, Cao, Zong-Xun, Li, Yong, Feng, Shun-Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2019
Materias:	Systematic Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558435/ https://www.ncbi.nlm.nih.gov/pubmed/31210718 http://dx.doi.org/10.3748/wjg.v25.i21.2675

Ejemplares similares

Proton pump inhibitors increase the severity of hepatic encephalopathy in cirrhotic patients
por: Fasullo, Matthew, et al.
Publicado: (2019)

Association between proton pump inhibitors and hepatic encephalopathy: A meta-analysis
por: Bian, Jin, et al.
Publicado: (2017)

The Use of Proton Pump Inhibitors and COVID-19: A Systematic Review and Meta-Analysis
por: Fatima, Kaneez, et al.
Publicado: (2022)

Association of proton pump inhibitors with risk of hepatic encephalopathy in advanced liver disease: A meta-analysis
por: Tantai, Xin-Xing, et al.
Publicado: (2019)

Proton pump inhibitors and colorectal cancer: A systematic review
por: Patel, Agastya, et al.
Publicado: (2021)

Paradoxical relationship between proton pump inhibitors and COVID-19: A systematic review and meta-analysis
por: Zippi, Maddalena, et al.
Publicado: (2021)

The Association between Baseline Proton Pump Inhibitors, Immune Checkpoint Inhibitors, and Chemotherapy: A Systematic Review with Network Meta-Analysis
por: Chang, Yu, et al.
Publicado: (2022)

Association of Proton Pump Inhibitor Therapy with Hepatic Encephalopathy in Hepatitis B Virus-related Acute-on-Chronic Liver Failure
por: Lin, Zhao-Ni, et al.
Publicado: (2014)

The Association between Proton Pump Inhibitors and the Effectiveness of CDK Inhibitors in HR+/HER- Advanced Breast Cancer Patients: A Systematic Review and Meta-Analysis
por: Chang, Yu-Cheng, et al.
Publicado: (2023)

Short-Term Proton Pump Inhibitor Use and Hepatic Encephalopathy Risk in Patients with Decompensated Cirrhosis
por: Kuan, Yi-Chun, et al.
Publicado: (2019)

The Impact of Concomitant Proton Pump Inhibitors on Immunotherapy Efficacy among Patients with Urothelial Carcinoma: A Meta-Analysis
por: Rizzo, Alessandro, et al.
Publicado: (2022)

Efficacy and Safety of Domperidone in Combination with Proton Pump Inhibitors in Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
por: Zamani, Nur Fathurah, et al.
Publicado: (2022)

Electroencephalography Signatures for Hepatic Encephalopathy in Cirrhosis Patients Treated with Proton Pump Inhibitors: An Exploratory Pilot Study
por: Zhang, Pan, et al.
Publicado: (2022)

Effect of long-term proton pump inhibitor administration on gastric mucosal atrophy: A meta-analysis
por: Li, Zhong, et al.
Publicado: (2017)

Impact of Proton Pump Inhibitors and Histamine-2-Receptor Antagonists on Non-Small Cell Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis
por: Rizzo, Alessandro, et al.
Publicado: (2022)

Proton pump inhibitor use does not increase dementia and Alzheimer’s disease risk: An updated meta-analysis of published studies involving 642305 patients
por: Song, Ya Qi, et al.
Publicado: (2019)

Efficacy of Proton Pump Inhibitors for Patients with Duodenal Ulcers: A Pairwise and Network Meta-Analysis of Randomized Controlled Trials
por: Hu, Zhan-Hong, et al.
Publicado: (2017)

Gastrointestinal symptoms associated with gastroesophageal reflux disease, and their relapses after treatment with proton pump inhibitors: A systematic review
por: Hosseini, Mousalreza, et al.
Publicado: (2017)

Impact of proton-pump inhibitors on the efficacy of immune checkpoint inhibitors in non-small cell lung cancer: A systematic review and meta-analysis
por: Dar, Sophia, et al.
Publicado: (2022)

Proton pump inhibitor use increases mortality and hepatic decompensation in liver cirrhosis
por: De Roza, Marianne Anastasia, et al.
Publicado: (2019)

Clopidogrel-Proton Pump Inhibitor Drug-Drug Interaction and Risk of Adverse Clinical Outcomes Among PCI-Treated ACS Patients: A Meta-analysis
por: Serbin, Michael A., et al.
Publicado: (2016)

Proton Pump Inhibitor Use and Risk of Gastric Cancer: Current Evidence from Epidemiological Studies and Critical Appraisal
por: Poly, Tahmina Nasrin, et al.
Publicado: (2022)

Risk of bias in non-randomized observational studies assessing the relationship between proton-pump inhibitors and adverse kidney outcomes: a systematic review
por: Rajan, Pradeep, et al.
Publicado: (2022)

The prognosis and incidence of hepatic encephalopathy of patients with liver cirrhosis treated with proton pump inhibitors: A multicenter retrospective study in Japan
por: Sakamaki, Akira, et al.
Publicado: (2021)

Systematic Review of the Economic Burden of Overt Hepatic Encephalopathy and Pharmacoeconomic Impact of Rifaximin
por: Neff, Guy, et al.
Publicado: (2018)

Proton pump inhibitors increase risk of COVID-19
Publicado: (2020)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

Exposure to proton pump inhibitors and risk of diabetes: A systematic review and meta-analysis
por: Guo, Yun-Ran, et al.
Publicado: (2023)

Does the use of proton pump inhibitors increase the risk of hypomagnesemia: An updated systematic review and meta-analysis
por: Liao, Shengtao, et al.
Publicado: (2019)

Proton Pump Inhibitors and Gastritis
por: Suzuki, Masayuki, et al.
Publicado: (2008)

Proton pump inhibitors and gastroenteritis
por: Hassing, Robert-Jan, et al.
Publicado: (2016)

Deprescribing proton pump inhibitors
por: Teh, Kim Jun Kevin, et al.
Publicado: (2023)

Altered Spontaneous Brain Activity in Cirrhotic Patients with Minimal Hepatic Encephalopathy: A Meta-Analysis of Resting-State Functional Imaging
por: Qin, Bin, et al.
Publicado: (2023)

Increased Risk of Fractures and Use of Proton Pump Inhibitors in Menopausal Women: A Systematic Review and Meta-Analysis
por: da Maia, Thuila Ferreira, et al.
Publicado: (2022)

Proton pump inhibitor use and risk of dementia: Systematic review and meta-analysis
por: Li, Min, et al.
Publicado: (2019)

A Patient on Long-Term Proton Pump Inhibitors Develops Sudden Seizures and Encephalopathy: An Unusual Presentation of Hypomagnesaemia
por: Gandhi, Nirav Y., et al.
Publicado: (2012)

Proton pump inhibitors increase the chemosensitivity of patients with advanced colorectal cancer
por: Wang, Xiaoyu, et al.
Publicado: (2017)

Increased Proton Pump Inhibitors−Induced Mortality Risk in Hemodialysis Patients
por: Sertorio, Jonas T., et al.
Publicado: (2018)

Using proton pump inhibitors increases the risk of hepato-biliary-pancreatic cancer. A systematic review and meta-analysis
por: Zhou, Wence, et al.
Publicado: (2022)

Comparison of the Efficacy of Polaprezinc Plus Proton Pump Inhibitor and Rebamipide Plus Proton Pump Inhibitor Treatments for Endoscopic Submucosal Dissection-induced Ulcers
por: Jung, Da Hyun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e7eqge5ehj341f66q55udfrimk